{"title":"急性心力衰竭患者谵妄的危险因素:系统回顾和荟萃分析。","authors":"Tetsushi Kawazoe, Tomoaki Ishida, Kohei Jobu, Kei Kawada, Shumpei Morisawa, Junko Tomida, Naomi Iihara, Yoichi Kawasaki, Yukihiro Hamada","doi":"10.1248/bpb.b24-00870","DOIUrl":null,"url":null,"abstract":"<p><p>Delirium is an acute, potentially life-threatening condition characterized by altered attention, disorganized thinking, and changes in consciousness. It frequently occurs in hospitalized patients with acute heart failure (AHF). In this meta-analysis, we aimed to identify risk factors for delirium in patients with AHF (AHF-D). We evaluated all original studies on delirium occurrence in patients hospitalized for AHF. On March 11, 2024, we searched PubMed, Scopus, Ichushi, and the Cochrane Library. Data extracted included: first author's name, publication year, inclusion/exclusion criteria, study design, delirium assessment methods, odds ratios with 95% confidence intervals, standardized mean differences, and other relevant findings. Of 2436 screened studies, 6 met eligibility criteria (3867 patients with AHF; 796 with delirium [20.6%] and 3071 without). Risk factors for AHF-D included older age; low body mass index; the use of mechanical ventilation/noninvasive positive pressure ventilation; comorbidities (previous stroke, dementia, and depression); use of antipsychotics and benzodiazepines; and laboratory findings on admission (elevated heart rate, B-type natriuretic peptide, blood urea nitrogen, serum creatinine, and low serum albumin and sodium levels). We identified 14 risk factors for AHF-D. These findings may help clinicians identify patients at high risk of developing AHF prior to delirium onset.</p>","PeriodicalId":8955,"journal":{"name":"Biological & pharmaceutical bulletin","volume":"48 7","pages":"1131-1141"},"PeriodicalIF":1.7000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Risk Factors for Delirium in Patients with Acute Heart Failure: A Systematic Review and Meta-Analysis.\",\"authors\":\"Tetsushi Kawazoe, Tomoaki Ishida, Kohei Jobu, Kei Kawada, Shumpei Morisawa, Junko Tomida, Naomi Iihara, Yoichi Kawasaki, Yukihiro Hamada\",\"doi\":\"10.1248/bpb.b24-00870\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Delirium is an acute, potentially life-threatening condition characterized by altered attention, disorganized thinking, and changes in consciousness. It frequently occurs in hospitalized patients with acute heart failure (AHF). In this meta-analysis, we aimed to identify risk factors for delirium in patients with AHF (AHF-D). We evaluated all original studies on delirium occurrence in patients hospitalized for AHF. On March 11, 2024, we searched PubMed, Scopus, Ichushi, and the Cochrane Library. Data extracted included: first author's name, publication year, inclusion/exclusion criteria, study design, delirium assessment methods, odds ratios with 95% confidence intervals, standardized mean differences, and other relevant findings. Of 2436 screened studies, 6 met eligibility criteria (3867 patients with AHF; 796 with delirium [20.6%] and 3071 without). Risk factors for AHF-D included older age; low body mass index; the use of mechanical ventilation/noninvasive positive pressure ventilation; comorbidities (previous stroke, dementia, and depression); use of antipsychotics and benzodiazepines; and laboratory findings on admission (elevated heart rate, B-type natriuretic peptide, blood urea nitrogen, serum creatinine, and low serum albumin and sodium levels). We identified 14 risk factors for AHF-D. These findings may help clinicians identify patients at high risk of developing AHF prior to delirium onset.</p>\",\"PeriodicalId\":8955,\"journal\":{\"name\":\"Biological & pharmaceutical bulletin\",\"volume\":\"48 7\",\"pages\":\"1131-1141\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biological & pharmaceutical bulletin\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1248/bpb.b24-00870\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biological & pharmaceutical bulletin","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1248/bpb.b24-00870","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
Risk Factors for Delirium in Patients with Acute Heart Failure: A Systematic Review and Meta-Analysis.
Delirium is an acute, potentially life-threatening condition characterized by altered attention, disorganized thinking, and changes in consciousness. It frequently occurs in hospitalized patients with acute heart failure (AHF). In this meta-analysis, we aimed to identify risk factors for delirium in patients with AHF (AHF-D). We evaluated all original studies on delirium occurrence in patients hospitalized for AHF. On March 11, 2024, we searched PubMed, Scopus, Ichushi, and the Cochrane Library. Data extracted included: first author's name, publication year, inclusion/exclusion criteria, study design, delirium assessment methods, odds ratios with 95% confidence intervals, standardized mean differences, and other relevant findings. Of 2436 screened studies, 6 met eligibility criteria (3867 patients with AHF; 796 with delirium [20.6%] and 3071 without). Risk factors for AHF-D included older age; low body mass index; the use of mechanical ventilation/noninvasive positive pressure ventilation; comorbidities (previous stroke, dementia, and depression); use of antipsychotics and benzodiazepines; and laboratory findings on admission (elevated heart rate, B-type natriuretic peptide, blood urea nitrogen, serum creatinine, and low serum albumin and sodium levels). We identified 14 risk factors for AHF-D. These findings may help clinicians identify patients at high risk of developing AHF prior to delirium onset.
期刊介绍:
Biological and Pharmaceutical Bulletin (Biol. Pharm. Bull.) began publication in 1978 as the Journal of Pharmacobio-Dynamics. It covers various biological topics in the pharmaceutical and health sciences. A fourth Society journal, the Journal of Health Science, was merged with Biol. Pharm. Bull. in 2012.
The main aim of the Society’s journals is to advance the pharmaceutical sciences with research reports, information exchange, and high-quality discussion. The average review time for articles submitted to the journals is around one month for first decision. The complete texts of all of the Society’s journals can be freely accessed through J-STAGE. The Society’s editorial committee hopes that the content of its journals will be useful to your research, and also invites you to submit your own work to the journals.